Epidemiological studies have clearly demonstrated that plasma concentrations of HDL cholesterol are strongly and inversely associated with cardiovascular risk. Besides playing a major role in reverse cholesterol transport, the process by which excess cholesterol in the arterial wall is removed by HDL and delivered to the liver for excretion, HDL have other atheroprotective functions. In particular, HDL can contribute to the maintenance of endothelial cell homeostasis by inhibiting cell adhesion molecule expression, by promoting the release of bioactive molecules such as nitric oxide and prostacyclin, and by regulating cell proliferation and migration. HDL inherited disorders represent a unique tool to understand the relationship between HDL concentration, HDL function and HDL-mediated atheroprotection.

HDL and endothelial protection : examining evidence from HDL inherited disorders / M. Gomaraschi, A. Ossoli, C. Vitali, L. Calabresi. - In: CLINICAL LIPIDOLOGY. - ISSN 1758-4299. - 8:3(2013 Jun), pp. 361-370. [10.2217/clp.13.30]

HDL and endothelial protection : examining evidence from HDL inherited disorders

M. Gomaraschi
Primo
;
A. Ossoli
Secondo
;
C. Vitali;L. Calabresi
Ultimo
2013-06

Abstract

Epidemiological studies have clearly demonstrated that plasma concentrations of HDL cholesterol are strongly and inversely associated with cardiovascular risk. Besides playing a major role in reverse cholesterol transport, the process by which excess cholesterol in the arterial wall is removed by HDL and delivered to the liver for excretion, HDL have other atheroprotective functions. In particular, HDL can contribute to the maintenance of endothelial cell homeostasis by inhibiting cell adhesion molecule expression, by promoting the release of bioactive molecules such as nitric oxide and prostacyclin, and by regulating cell proliferation and migration. HDL inherited disorders represent a unique tool to understand the relationship between HDL concentration, HDL function and HDL-mediated atheroprotection.
apoA-I; atherosclerosis; CETP deficiency; endothelium; genetic HDL disorders; HDL; LCAT deficiency
Settore BIO/14 - Farmacologia
Article (author)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/234626
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 2
social impact